Corcept Therapeutics Inc (CORT)
24.52
-0.54
(-2.15%)
USD |
NASDAQ |
May 03, 16:00
24.98
+0.46
(+1.88%)
After-Hours: 20:00
Corcept Therapeutics Price: 24.52 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 25.06 | 25.22 | 23.11 | 24.52 | 1.698M |
May 02, 2024 | 26.39 | 26.39 | 23.80 | 25.06 | 2.274M |
May 01, 2024 | 23.09 | 24.61 | 22.60 | 23.88 | 1.828M |
Apr 30, 2024 | 23.47 | 23.94 | 23.28 | 23.32 | 1.789M |
Apr 29, 2024 | 23.03 | 23.58 | 22.79 | 23.37 | 556258.0 |
Apr 26, 2024 | 22.28 | 23.22 | 22.28 | 22.80 | 820551.0 |
Apr 25, 2024 | 22.47 | 22.73 | 22.00 | 22.21 | 1.176M |
Apr 24, 2024 | 23.00 | 23.29 | 22.04 | 22.48 | 1.088M |
Apr 23, 2024 | 22.76 | 24.23 | 22.36 | 23.00 | 1.885M |
Apr 22, 2024 | 21.32 | 22.79 | 20.84 | 22.30 | 3.898M |
Apr 19, 2024 | 22.60 | 23.03 | 22.56 | 22.95 | 924783.0 |
Apr 18, 2024 | 22.87 | 23.44 | 22.57 | 22.66 | 971180.0 |
Apr 17, 2024 | 23.52 | 23.54 | 22.76 | 23.00 | 957823.0 |
Apr 16, 2024 | 23.02 | 23.65 | 22.76 | 23.39 | 714294.0 |
Apr 15, 2024 | 23.50 | 23.63 | 22.91 | 23.15 | 724423.0 |
Apr 12, 2024 | 23.66 | 23.82 | 23.31 | 23.51 | 426853.0 |
Apr 11, 2024 | 24.01 | 24.10 | 23.39 | 23.82 | 569115.0 |
Apr 10, 2024 | 24.72 | 24.72 | 23.19 | 23.80 | 818119.0 |
Apr 09, 2024 | 24.32 | 25.64 | 24.25 | 25.46 | 855619.0 |
Apr 08, 2024 | 25.50 | 25.50 | 24.01 | 24.23 | 952848.0 |
Apr 05, 2024 | 25.08 | 25.37 | 24.86 | 25.20 | 723284.0 |
Apr 04, 2024 | 25.83 | 26.01 | 25.00 | 25.05 | 776691.0 |
Apr 03, 2024 | 25.26 | 25.68 | 25.09 | 25.65 | 569606.0 |
Apr 02, 2024 | 25.27 | 25.38 | 24.88 | 25.36 | 1.033M |
Apr 01, 2024 | 24.95 | 26.10 | 24.94 | 25.74 | 838044.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
9.78
Minimum
May 31 2019
33.80
Maximum
Sep 14 2023
20.74
Average
21.63
Median
Mar 30 2023
Price Benchmarks
Ultragenyx Pharmaceutical Inc | 42.75 |
Alnylam Pharmaceuticals Inc | 152.33 |
Catalyst Pharmaceuticals Inc | 14.72 |
United Therapeutics Corp | 262.40 |
XOMA Corp | 24.78 |
Price Related Metrics
PE Ratio | 25.81 |
PS Ratio | 5.679 |
PEG Ratio | 3.245 |
Price to Book Value | 5.009 |
Price to Free Cash Flow | 21.59 |
Earnings Yield | 3.87% |
Market Cap | 2.538B |
PEGY Ratio | 3.245 |
Operating PE Ratio | 25.54 |
Normalized PE Ratio | 25.81 |